Phase 3 Failure Keeps AstraZeneca and Ionis Out of a Growing Heart Disease Market
AstraZeneca and Ionis Pharmaceuticals drug eplontersen, brand name Wainua, failed a Phase 3 test in…
Phase 3 Failure Keeps AstraZeneca and Ionis Out of a Growing Heart Disease Market
AstraZeneca and Ionis Pharmaceuticals drug eplontersen, brand name Wainua, failed a Phase 3 test in cardiomyopathy caused by transthyretin amyloidosis. More details will be shared at a medical conference next month, but it appears the RNA therapy’s slim hopes now ride on a subgroup analysis. The post Phase 3 Failure Keeps AstraZeneca and Ionis Out…
A Look at 1115 Waiver Evaluations for Medicaid Payments to Institutions of Mental Disease (IMD) for Substance Use Disorder
As SUD IMD waiver evaluations and renewals are becoming available, states face a shifting Medicaid and policy and waiver landscape. This brief examines findings from the first available summative evaluations for SUD IMD waivers and what they show about progress toward meeting goals and milestones.
Menopause Is an Overlooked Driver of Cost in High-Risk Populations
For someone already managing chronic disease, menopause can disrupt stability and complicate treatment plans in ways that aren’t always immediately visible but show up over time in outcomes and utilization. The post Menopause Is an Overlooked Driver of Cost in High-Risk Populations appeared first on MedCity News.
Who Are Direct Care Workers and How Might Federal Policy Changes Impact the Workforce?
This analysis uses the 2024 American Community Survey (ACS) to provide an overview of demographic and socioeconomic characteristics of the direct care workforce, including home health aides, personal care aides, and nursing assistants who work in nursing facilities, residential care facilities, home health, and settings that provide nonresidential services for older adults and younger adults…
Specialty Pharmacy Is No Longer Optional Infrastructure
The organizations that move now — with the right foundation and the right partners — will enter the next planning cycle with a specialty pharmacy that functions as a true strategic asset. The post Specialty Pharmacy Is No Longer Optional Infrastructure appeared first on MedCity News.
Brain Interfaces Don’t Need Surgery to Be Transformative – and the Distinction Is Now a Strategic One
Non-surgical implantable BCI is increasingly capable of matching surgical performance while transforming the risk-benefit equation, and it is now the most credible path along all three dimensions simultaneously. The post Brain Interfaces Don’t Need Surgery to Be Transformative – and the Distinction Is Now a Strategic One appeared first on MedCity News.
New KFF Poll Examines Patterns of Belief Across Common Vaccine Myths — The Monitor
KFF’s latest Tracking Poll on Health Information and Trust shows that larger shares of the public express uncertainty over common vaccine myths than definitive belief. The latest analysis shows which adults are consistent myth believers, consistent myth deniers, and those who fall in the “mixed middle.”
My Search for a Psychiatric Bed in an Overburdened Health System
If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by dialing or texting “988.” Eight days before my 33rd birthday in April, a social worker at a crisis clinic near Denver determined I was an imminent danger to myself. She placed me on an…
MGB Nurses, Home Health Staff Launch Strike Over Wages, Benefits
More than 4,000 Brigham and Women’s Hospital nurses and 450 home health workers launched Massachusetts’ largest-ever healthcare strike this week over stalled contract talks on wages and benefits. The strike quickly prompted Governor Maura Healey to step in and convene both sides at the State House, but it remains unclear whether a deal is near….
Vera Therapeutics’ First-in-Class Kidney Disease Drug Lands Speedy FDA Approval
FDA approval of Vera Therapeutics’ Trutakna makes it first in a new class of medicines designed to block two targets to treat immunoglobulin A nephropathy, an autoimmune disease that can progress to end-stage renal failure. Competition looms from Vertex Pharmaceuticals, on track to receive a November regulatory decision for a drug designed to block the…
